A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy

Human Reproduction

Volumn 13, Issue 4, 1998, Pages 1057-1062

  Evans, P W ^a   Wheeler, T ^a   Anthony, F W ^a   Osmond, C ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Human chorionic gonadotrophin; In vitro fertilization; Oestradiol; Pregnancy; Vascular endothelial growth factor

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; PROGESTERONE; VASCULOTROPIN;

ARTICLE; BIRTH RATE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; CRYOPRESERVATION; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FIRST TRIMESTER PREGNANCY; HORMONE SUBSTITUTION; HUMAN; LONGITUDINAL STUDY; MATERNAL BLOOD; NORMAL HUMAN; PREGNANCY RATE; PROGESTERONE BLOOD LEVEL; TWIN PREGNANCY;

EID: 0031810711     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.4.1057     Document Type: Article

References (45)

1. Adair, T.H., Gay, W.J. and Montani, J-P. (1990) Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am. J. Physiol., 259, R393-R404.
2. Aderka, D., Engelmann, H., Maor, Y. et al. (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med., 175, 323-329.
3. Anumba, D., Ford, G., Boys, R. et al. (1996) The role of nitric oxide in the modulation of vascular tone in normal pregnancy, Br. J. Obstet. Gynecol., 103, 1169-1170.
4. Anthony, F.W., Evans, P.W., Wheeler, T. et al. (1997) Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann. Clin. Biochem., 34, 276-280.
5. Baker, P.N., Davidge, ST. and Roberts, J.M. (1995) Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension, 26, 244-248.
6. Baker, P.N., Davidge, S.T., Pitt, B.R. et al. (1997) Plasma from preeclamptic women causes a rapid, calcium-sensitive release of nitric oxide from vascular smooth muscle cells. Hypertension in Pregnancy, 16, 47-63.
7. Barleon, B., Sozzani, S., Zhou, D. et al. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood, 87, 3336-3343.
8. Cao, Y.H., Linden, P., Shima, D. et al. (1996) In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest., 98, 2507-2511.
9. Capeless, E.L. and Clapp, J.F. (1989) Cardiovascular changes in early phase of pregnancy. Am. J. Obstet. Gynecol., 161, 1449-1453.
10. Carmeliet, P., Ferreira, V., Breier, G. et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439.
11. Charnock-Jones, D.S., Sharkey, A.M., Boocock, C.A. et al. (1994) Vascular endothelial growth factor receptor localisation and activation in human trophoblast and choriocarcinoma cells. Biol. Reprod., 51, 524-530.
12. Charnock-Jones, D.S., Clark, D.E., He, Y.L. et al. (1997) Placental production of a locally and systemically acting soluble factor which inhibits vascular endothelial growth factor (VEGF). J. Soc. Gynecol. Invest., 4, no. 1 (suppl), abst 438.
13. Clark, D.E., Smith, S.K., Sharkey, A.M. et al. (1996) Localization of VEGF and expression of its receptors fit and KDR in human placenta throughout pregnancy. Hum. Reprod., 11, 1090-1098.
14. Conrad, K.P., Joffe, G.M., Kruszyna, H. et al. (1993) Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J., 7, 566-571.
15. de Crespigny, L., Robinson, H.P., Murphy, A. et al. (1985) Gestation sac size in in-vitro fertilization pregnancies. Br. J. Obstet, Gynaecol., 92, 953-956.
16. Duvekot, J.J., Cheriex, E.C., Pieters, F.A.A. et al. (1993) Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am. J. Obstet. Gynecol., 169, 1382-1392.
17. Fox, H. (1970) Effect of hypoxia on trophoblast in organ culture. Am. J. Obstet. Gynecol., 107, 1058-1064.
18. Goetz, R.M., Morano, I., Calovini, T. et al. (1994) Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem. Biophys. Res. Commun., 205, 905-910.
19. Hermsteiner, M.G.J., Zoltan, D.R. and Clapp, J.F. III (1997) Human chorionic gonadotrophin is a potent vasodilator of pre-arteriolar uterine and mesenteric vessels in pregnant and nonpregnant rats. J. Soc. Gynecol. Invest., 4, no. 1 (suppl), abst 123.
20. Hishikawa, K., Nakaki, T., Marumo, T. et al. (1995) Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett., 360, 291-293.
21. Jackson, M.R., Carney, E.W., Lye, S.J. et al. (1994) Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta, 15, 341-353.
22. Joukov, V., Pajusola, K., Kaipainen, A. et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15, 290-298.
23. Kamat, B.R., Brown, L.F., Manseau, E.J. et al. (1995) Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Am. J. Path., 146, 157-165.
24. Kendall, R.L. and Thomas, K.A. (1993) Inhibition of vascular endothelial cell growth activity by an endogenously encoded soluble receptor. Proc. Natl Acad. Sci., 9, 10709.
25. Klauber, N., Rohan, R.M., Flynn, E. et al. (1997) Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470. Nat. Med., 3, 443-446.
26. Krasnow, J.S., Berga, S.L., Guzick, D.S. et al. (1996) Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril., 65, 552-555.
27. Li, X.F., Gregory, J. and Ahmed, A. (1994) Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors, 11, 277-282.
28. Lyall, F., Greer, I.A., Boswell, F. et al. (1997) Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br. J. Obstet. Gynaecol., 104, 223-228.
29. Neulen, J., Van, Z., Raczek, S. et al. (1995) Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab., 80, 1967-1971.
30. Robertson, D., Selleck, K., Suikkari, A-M. et al. (1995) Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment. Hum. Reprod., 10, 2478-2482.
31. Rodesch, F., Simon, P., Donner, C. et al. (1992) Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet. Gynecol., 80, 283-285.
32. Rodway, M.R. and Rao, C.V. (1995) A novel perspective on the role of human chorionic gonadotrophin during pregnancy and in gestational trophoblastic disease. Early Pregnancy: Biology and Medicine, 1, 176-187.
33. Salas, S.P., Altermatt, F., Campos, M. et al. (1995) Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension, 26, 1019-1023.
34. Schweiki, D., Itin, A., Soffer, D. et al. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature, 359, 843-845.
35. Shalaby, F., Rossant, J., Yamaguchi, T.P. et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature, 376, 62-66.
36. Sharkey, A.M., Charnock-Jones, D.S., Boocock, C.A. et al. (1993) Expression of mRNA for vascular endothelial growth factor in human placenta. J. Reprod. Fertil., 99, 609-615.
37. Sharkey, A.M., Cooper, J.C., Balmforth, J.R. et al. (1996) Maternal plasma concentrations of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Eur. J. Clin. Invest., 26, 1182-1185.
38. Shiraishi, S., Nakagawa, K., Kinukawa, N. et al., (1996) Immunohistochemical localization of vascular endothelial growth factor in the human placenta. Placenta, 17, 111-121.
39. Taylor, C.M., Stevens, H., Anthony, F.W. et al. (1997) Influence of hypoxia on vascular endothelial growth factor and chorionic gonadotrophin production in the trophoblast-derived cell lines: JEG. JAR and BeWo. Placenta, 18, 181-188.
40. Van Zee, K.J., Kohono, T., Fisher, E. et al. (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor-α in vitro and in vivo. Proc. Natl. Acad. Sci. USA, 89, 4845-4849.
41. Weiner, C.P., Lizasoain, I., Baylis, S.A. et al. (1994) Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA, 91, 5212-5216.
42. Wheeler, T., Elcock, C.L. and Anthony, F.W. (1995) Angiogenesis and the placental environment. Placenta, 16, 289-296.
43. Wheeler, T., Brockelsby, J.C., Wellings, R.P. et al. (1997) Serum concentrations of vascular endothelial growth factor are raised in pre-eclamptic versus normotensive women. J. Soc. Gynecol. Invest., 4, 194A.
44. Whittaker, P. and Lind, T. (1993) The intravascular mass of albumen during human pregnancy: a serial study in normal and diabetic women. Br. J. Obstet. Gynaecol., 100, 587-592.
45. Yang, R., Thomas, G.R., Bunting, S. et al. (1996) Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J. Cardiovasc. Pharmacol., 27, 838-844.